Literature DB >> 12808130

Inducible nitric oxide synthase expression inhibition by adenovirus E1A.

Wangsen Cao1, Clare Bao, Charles J Lowenstein.   

Abstract

Nitric oxide (NO) is an antiviral effector of the innate immune system. Viruses that can interfere with NO synthesis may be able to replicate more rapidly than viruses that cannot limit NO synthesis. We show that the adenovirus E1A protein inhibits NO production by decreasing expression of the inducible NO synthase (NOS2). The amino-terminal portion of E1A decreases transactivation of the NOS2 5'-flanking region, limiting the DNA binding activity of NF-kappaB and inhibiting NOS2 expression. E1A is thus able to deactivate a critical component of the host defense against viral infection. Viral inhibition of NO production is a mechanism that may enable certain viruses to evade the host innate immune system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808130      PMCID: PMC164663          DOI: 10.1073/pnas.1337185100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

Review 1.  Adenovirus immunoregulatory genes and their cellular targets.

Authors:  M S Horwitz
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

2.  A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity.

Authors:  D Chakravarti; V Ogryzko; H Y Kao; A Nash; H Chen; Y Nakatani; R M Evans
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

3.  Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter.

Authors:  T Agalioti; S Lomvardas; B Parekh; J Yie; T Maniatis; D Thanos
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

4.  Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase.

Authors:  A Pellacani; M T Chin; P Wiesel; M Ibanez; A Patel; S F Yet; C M Hsieh; J D Paulauskis; R Reeves; M E Lee; M A Perrella
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

5.  Direct suppression of Stat1 function during adenoviral infection.

Authors:  D C Look; W T Roswit; A G Frick; Y Gris-Alevy; D M Dickhaus; M J Walter; M J Holtzman
Journal:  Immunity       Date:  1998-12       Impact factor: 31.745

6.  Adenovirus infection increases iNOS and peroxynitrite production in the lung.

Authors:  Z K Zsengellér; G F Ross; B C Trapnell; C Szabó; J A Whitsett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

7.  The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.

Authors:  P Krajcsi; T Dimitrov; T W Hermiston; A E Tollefson; T S Ranheim; S B Vande Pol; A H Stephenson; W S Wold
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.

Authors:  M A Perrella; A Pellacani; P Wiesel; M T Chin; L C Foster; M Ibanez; C M Hsieh; R Reeves; S F Yet; M E Lee
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

9.  Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.

Authors:  M Li; G Pascual; C K Glass
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

10.  Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter.

Authors:  B S Parekh; T Maniatis
Journal:  Mol Cell       Date:  1999-01       Impact factor: 17.970

View more
  8 in total

1.  Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage.

Authors:  Bing Wang; Xiaolei Zhu; YunTai Kim; Jie Li; Siyuan Huang; Sofiyan Saleem; Rung-chi Li; Yun Xu; Sylvain Dore; Wangsen Cao
Journal:  Free Radic Biol Med       Date:  2011-12-17       Impact factor: 7.376

Review 2.  Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens.

Authors:  Carolina Prolo; María Noel Alvarez; Rafael Radi
Journal:  Biofactors       Date:  2013-11-26       Impact factor: 6.113

3.  Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway.

Authors:  Shaoguang Wu; Jan Powell; Nes Mathioudakis; Sheryl Kane; Ellen Fernandez; Cynthia L Sears
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Characterization of short range DNA looping in endotoxin-mediated transcription of the murine inducible nitric-oxide synthase (iNOS) gene.

Authors:  Hongtao Guo; Zhiyong Mi; Paul C Kuo
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

5.  Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production.

Authors:  Malin Stoltz; Clas Ahlm; Ake Lundkvist; Jonas Klingström
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

6.  Mesenchymal stem cells: a double-edged sword in regulating immune responses.

Authors:  W Li; G Ren; Y Huang; J Su; Y Han; J Li; X Chen; K Cao; Q Chen; P Shou; L Zhang; Z-R Yuan; A I Roberts; S Shi; A D Le; Y Shi
Journal:  Cell Death Differ       Date:  2012-03-16       Impact factor: 15.828

7.  Up-Regulation of Human Inducible Nitric Oxide Synthase by p300 Transcriptional Complex.

Authors:  Zhong Guo; Liang Zheng; Xinghua Liao; David Geller
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

8.  Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling.

Authors:  Wangsen Cao; Clare Bao; Elizaveta Padalko; Charles J Lowenstein
Journal:  J Exp Med       Date:  2008-05-26       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.